Terms: = Thyroid cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
65 results:
1. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
2. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
Oncotarget; 2024 Feb; 15():106-116. PubMed ID: 38329731
[TBL] [Abstract] [Full Text] [Related]
3. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary thyroid Carcinoma: A Pitfall in thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
4. Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype.
Zhou J; Wang WR; Zhang HF; Gao QQ; Wang WB; Zhu JH; Han YS; Chen J; Ma TH; Zhang XY; Teng XD
Front Endocrinol (Lausanne); 2023; 14():1138100. PubMed ID: 37124750
[TBL] [Abstract] [Full Text] [Related]
5. Entrectinib in the neoadjuvant setting of anaplastic thyroid cancer: a case report.
Damásio I; Simões-Pereira J; Donato S; Horta M; Cavaco BM; Rito M; Gomes P; Leite V
Eur Thyroid J; 2023 Feb; 12(1):. PubMed ID: 36378538
[TBL] [Abstract] [Full Text] [Related]
6. [Comparison of the methods for detecting NTRK gene fusion variations in papillary thyroid carcinoma].
Jiang YY; Chen H; Xu BL; Wang S
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):726-732. PubMed ID: 35922162
[No Abstract] [Full Text] [Related]
7. Limited Accuracy of Pan-Trk Immunohistochemistry Screening for
Macerola E; Proietti A; Poma AM; Vignali P; Sparavelli R; Ginori A; Basolo A; Elisei R; Santini F; Basolo F
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806472
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of EVT6-NTRK3-Dependent Papillary thyroid cancer Using Minor Expression Profile.
Kechin AA; Ivanov AA; Kel AE; Kalmykov AS; Oskorbin IP; Boyarskikh UA; Kharpov EA; Bakharev SY; Oskina NA; Samuilenkova OV; Vikhlyanov IV; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2022 Jun; 173(2):252-256. PubMed ID: 35737155
[TBL] [Abstract] [Full Text] [Related]
9. Histopathological Characteristics of N1b Papillary thyroid Carcinoma are Associated with Risk of Recurrence.
Carmel Neiderman NN; Duek I; Kuzmenko B; Ringel B; Warshavsky A; Muhanna N; Horowitz G; Fliss DM
World J Surg; 2022 Aug; 46(8):1917-1925. PubMed ID: 35543736
[TBL] [Abstract] [Full Text] [Related]
10. Unique Molecular Signatures Are Associated with Aggressive Histology in Pediatric Differentiated thyroid cancer.
Mollen KP; Shaffer AD; Yip L; Monaco SE; Huyett P; Viswanathan P; Witchel SF; Duvvuri U; Simons JP
Thyroid; 2022 Mar; 32(3):236-244. PubMed ID: 34915753
[No Abstract] [Full Text] [Related]
11. Secretory Carcinoma of the thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic Features.
Saliba M; Mohanty AS; Ho AL; Drilon A; Dogan S
Head Neck Pathol; 2022 Jun; 16(2):612-620. PubMed ID: 34655408
[TBL] [Abstract] [Full Text] [Related]
12. Secretory Carcinoma of the Salivary Gland: A Rarity in Children.
Kelly GA; Venkatramani R; Quintanilla NM; Chelius DC; Roy A; Mahajan P
J Pediatr Hematol Oncol; 2022 May; 44(4):167-172. PubMed ID: 34486543
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Pathology of thyroid Tumors: Old Problems and New Concepts.
Hernandez-Prera JC
Surg Pathol Clin; 2021 Sep; 14(3):493-506. PubMed ID: 34373098
[TBL] [Abstract] [Full Text] [Related]
14. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract] [Full Text] [Related]
15. Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an etv6-NTRK3 fusion in both components.
Xu J; Weisman P
Genes Chromosomes Cancer; 2021 Jun; 60(6):447-451. PubMed ID: 33342011
[TBL] [Abstract] [Full Text] [Related]
16. Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
Huang NS; Cao YM; Lu ZW; Guan Q; Chen JY; Ma B; Chen TZ; Bai QM; Wang YL; Ji QH
Oral Oncol; 2021 Apr; 115():105092. PubMed ID: 33189578
[TBL] [Abstract] [Full Text] [Related]
17. Detection of NTRK1/3 Rearrangements in Papillary thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
[TBL] [Abstract] [Full Text] [Related]
18. The Clinicopathological Results of thyroid cancer With BRAFV600E Mutation in the Young Population of Fukushima.
Iwadate M; Mitsutake N; Matsuse M; Fukushima T; Suzuki S; Matsumoto Y; Ookouchi C; Mizunuma H; Nakamura I; Nakano K; Sakamoto A; Hirokawa M; Ito M; Naganuma H; Hashimoto Y; Shimura H; Yamashita S; Suzuki S
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32827026
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
20. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
[TBL] [Abstract] [Full Text] [Related]
[Next]